InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-07-22 | Lisa McClain(R-MI09) | house | Sale | $1,001 - $15,000 |
| 2025-06-17 | Lisa McClain(R-MI09) | house | Purchase | $1,001 - $15,000 |
| 2025-04-08 | Rob Bresnahan(R-PA08) | house | Sale | $1,001 - $15,000 |
| 2025-02-25 | Rob Bresnahan(R-PA08) | house | Purchase | $1,001 - $15,000 |
| 2025-02-13 | Jared Moskowitz(D-FL23) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $3.07B+6.3% | $2.89B-1.9% | $2.95B+2.2% | $2.89B+2.0% | $2.83B |
| Cost of goods and services sold | $1.97B+4.0% | $1.89B+4.1% | $1.82B+4.0% | $1.75B+5.7% | $1.66B |
| Gross profit | $1.10B+10.6% | $998.5M-11.6% | $1.13B-0.6% | $1.14B-3.4% | $1.18B |
| Research and development | $74.3M+7.5% | $69.1M+1.0% | $68.4M+16.9% | $58.5M+10.8% | $52.8M |
| Selling, general and administrative expenses | $393.6M+16.3% | $338.5M-4.2% | $353.4M+11.5% | $316.9M-12.7% | $362.8M |
| Other expense (income) (Note 16) | $51.2M+143.8% | $21.0M-33.1% | $31.4M+17.2% | $26.8M+239.2% | $7.9M |
| Operating profit | $584.9M+2.6% | $569.9M-15.7% | $676.0M-7.9% | $734.0M-2.4% | $752.3M |
| Interest expense | $500K-83.3% | $3.0M-66.7% | $9.0M+13.9% | $7.9M-3.7% | $8.2M |
| Interest income | -$17.5M+10.7% | -$19.6M+30.0% | -$28.0M-449.0% | -$5.1M-410.0% | -$1.0M |
| Other nonoperating expense (income) | $1.0M+0.0% | $1.0M+133.3% | -$3.0M-105.8% | $51.3M | — |
| Income before income taxes and equity in net income of affiliated companies | $600.9M+2.6% | $585.5M-16.1% | $698.0M+2.7% | $679.9M-9.2% | $748.9M |
| Income tax expense | $121.6M+13.1% | $107.5M-12.1% | $122.3M+6.6% | $114.7M+7.0% | $107.2M |
| Equity in net income of affiliated companies | -$14.4M+2.0% | -$14.7M+16.9% | -$17.7M+14.5% | -$20.7M-3.0% | -$20.1M |
| Net income | $493.7M+0.2% | $492.7M-17.0% | $593.4M+1.3% | $585.9M-11.5% | $661.8M |
| Basic (in dollars per share) | $6.8M+1.2% | $6.8M-15.4% | $8.0M+1.4% | $7.9M-11.5% | $8.9M |
| Diluted (in dollars per share) | $6.8M+1.5% | $6.7M-15.1% | $7.9M+1.9% | $7.7M-10.8% | $8.7M |
| Basic (in shares) | $72.3M-1.0% | $73.0M-1.7% | $74.3M-0.1% | $74.4M+0.0% | $74.4M |
| Diluted (in shares) | $72.7M-1.4% | $73.7M-2.1% | $75.3M-0.7% | $75.8M-0.7% | $76.3M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Notable healthcare headlines for the week: Merck, Eli Lilly, and GE HealthCare in focus
Is West Pharmaceutical Services (WST) Pricing Look Stretched After Strong 1 Year Rally?
Top 50 High-Quality Dividend Growth Stocks For May 2026
Dividend Champion, Contender, And Challenger Highlights: Week Of May 3